JP2021522825A5 - - Google Patents
Info
- Publication number
- JP2021522825A5 JP2021522825A5 JP2020563545A JP2020563545A JP2021522825A5 JP 2021522825 A5 JP2021522825 A5 JP 2021522825A5 JP 2020563545 A JP2020563545 A JP 2020563545A JP 2020563545 A JP2020563545 A JP 2020563545A JP 2021522825 A5 JP2021522825 A5 JP 2021522825A5
- Authority
- JP
- Japan
- Prior art keywords
- domain
- vector
- isolated polypeptide
- nucleic acid
- sgrna
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862670135P | 2018-05-11 | 2018-05-11 | |
| US62/670,135 | 2018-05-11 | ||
| PCT/CA2019/050629 WO2019213776A1 (en) | 2018-05-11 | 2019-05-10 | Crispr/cas9 system and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021522825A JP2021522825A (ja) | 2021-09-02 |
| JP2021522825A5 true JP2021522825A5 (https=) | 2022-05-13 |
| JPWO2019213776A5 JPWO2019213776A5 (https=) | 2022-05-13 |
Family
ID=68467641
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020563545A Pending JP2021522825A (ja) | 2018-05-11 | 2019-05-10 | ＣＲＩＳＰＲ／Ｃａｓ９システムおよびその使用 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US12378549B2 (https=) |
| JP (1) | JP2021522825A (https=) |
| CA (1) | CA3101949A1 (https=) |
| WO (1) | WO2019213776A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202313985A (zh) * | 2021-05-16 | 2023-04-01 | 香港商正基基因科技有限公司 | 富集靶向核酸、鑑別脫靶及評估基因編輯效率之方法 |
| GB202109675D0 (en) * | 2021-07-05 | 2021-08-18 | Ucl Business Ltd | Treatment for tyrosine degradation-associated disorders |
| IL324634A (en) | 2023-05-15 | 2026-01-01 | Nchroma Bio Inc | Compositions and methods for epigenetic regulation of hbv gene expression |
| WO2025194124A1 (en) * | 2024-03-14 | 2025-09-18 | Tessera Therapeutics, Inc. | Modified st1cas9 guide nucleic acids |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014093718A1 (en) | 2012-12-12 | 2014-06-19 | The Broad Institute, Inc. | Methods, systems, and apparatus for identifying target sequences for cas enzymes or crispr-cas systems for target sequences and conveying results thereof |
| JP6793547B2 (ja) * | 2013-12-12 | 2020-12-02 | ザ・ブロード・インスティテュート・インコーポレイテッド | 最適化機能ＣＲＩＳＰＲ−Ｃａｓ系による配列操作のための系、方法および組成物 |
| AU2014361834B2 (en) * | 2013-12-12 | 2020-10-22 | Massachusetts Institute Of Technology | CRISPR-Cas systems and methods for altering expression of gene products, structural information and inducible modular Cas enzymes |
| US10900034B2 (en) * | 2014-12-03 | 2021-01-26 | Agilent Technologies, Inc. | Guide RNA with chemical modifications |
| JP7109784B2 (ja) * | 2015-10-23 | 2022-08-01 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 遺伝子編集のための進化したＣａｓ９蛋白質 |
-
2019
- 2019-05-10 CA CA3101949A patent/CA3101949A1/en active Pending
- 2019-05-10 WO PCT/CA2019/050629 patent/WO2019213776A1/en not_active Ceased
- 2019-05-10 US US17/054,008 patent/US12378549B2/en active Active
- 2019-05-10 JP JP2020563545A patent/JP2021522825A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12570971B2 (en) | Contiguity preserving transposition | |
| JP2025170240A5 (https=) | ||
| CA3128755C (en) | Compositions and methods for treating hemoglobinopathies | |
| Lehmann et al. | The importance of internal loops within RNA substrates of ADAR1 | |
| JP2021522825A5 (https=) | ||
| JPWO2021050571A5 (https=) | ||
| JP2019536425A5 (https=) | ||
| WO2019042284A1 (en) | FUSION PROTEINS FOR ENHANCED PRECISION IN THE BASIC EDITION | |
| EP4227412A1 (en) | Engineered guide rna for increasing efficiency of crispr/cas12f1 (cas14a1) system, and use thereof | |
| GB2556276A (en) | Engineered crispr-CAS9 compositions and methods of use | |
| CN107130000A (zh) | 一种同时敲除KRAS基因和EGFR基因的CRISPR‑Cas9系统及其应用 | |
| RU2022103641A (ru) | Искусственная модификация генома для регуляции экспрессии гена | |
| JP2025183226A5 (https=) | ||
| ES2667346T9 (es) | Estrategias de secuenciación de región genómica 3-D de interés | |
| JPWO2021016453A5 (https=) | ||
| JP2021518159A5 (https=) | ||
| RU2022105597A (ru) | Искусственно созданная система управления функцией шк | |
| JPWO2021102390A5 (https=) | ||
| JP2002542837A (ja) | 核酸の増幅方法 | |
| JPWO2022256440A5 (https=) | ||
| JPWO2019213776A5 (https=) | ||
| JPWO2021041885A5 (https=) | ||
| JPWO2022081890A5 (https=) | ||
| JPWO2023081855A5 (https=) | ||
| JPWO2020219908A5 (https=) |